Implementing food-based dietary guidelines for - United Nations ...

More documents

Recommendations

Info

S112 adult-type hypolactasia. Nat Genet 2002;30:233–7. 12. Tishkoff SA, Verrelli BC. Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu Rev Genomics Hum Genet 2003;4:293–340. 13. Guttmacher AE, Collins FS. Genomic medicine—A primer. N Engl J Med 2002;347:1512–20. 14. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304–51. 15. Tishkoff SA, Kidd KK. Implications of biogeography of human populations for ‘race’ and medicine. Nat Genet 2004;36(11 suppl):S21–7. 16. Nachman MW, Crowell SL. Estimate of the mutation rate per nucleotide in humans. Genetics 2000;156:297–304. 17. Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 2003;4:587–97. 18. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. The structure of haplotype blocks in the human genome. Science 2002;296:2225–9. 19. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med 2005;56: 303–20. 20. Van Blerkom LM. Role of viruses in human evolution. Am J Phys Anthropol 2003;suppl 37:14–46. 21. Brookfield JF. Mobile DNAs: The poacher turned gamekeeper. Curr Biol 2003;13:R846–7. 22. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet 2002;3:370–9. 23. Bamshad M, Wooding SP. Signatures of natural selection in the human genome. Nat Rev Genet 2003;4:99–111. 24. Waterland RA, Jirtle RL. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293–300. 25. Friso S, Choi SW. Gene-nutrient interactions and DNA methylation. J Nutr 2002;132(8 suppl):2382S–7S. 26. Friso S, Choi SW, Dolnikowski GG, Selhub J. A method to assess genomic DNA methylation using high-performance liquid chromatography/electrospray ionization mass spectrometry. Anal Chem 2002;74:4526–31. 27. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr 1999;69:179–97. 28. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290–5. 29. Fenech M. Micronutrients and genomic stability: A new paradigm for recommended dietary allowances (RDAs). Food Chem Toxicol 2002;40:1113–7. 30. Fenech M. Genome health nutrigenomics: Nutrition and the science of optimal genome maintenance. Asia Pac J Clin Nutr 2004;13(suppl):S15. 31. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 2002;7:1128–37. 32. Fenech M. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res 2001;480–481:51–4. P. J. Stover 33. Mishra HN, Das C. A review on biological control and metabolism of aflatoxin. Crit Rev Food Sci Nutr 2003; 43:245–64. 34. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001;475:7–20. 35. Goswami T, Rolfs A, Hediger MA. Iron transport: Emerging roles in health and disease. Biochem Cell Biol 2002;80:679–89. 36. Hediger MA, Rolfs A, Goswami T. Iron transport and hemochromatosis. J Investig Med 2002;50:239S–46S. 37. Wolfe KH, Li WH. Molecular evolution meets the genomics revolution. Nat Genet 2003;33 suppl:255–65. 38. Cooper DN, Krawczak M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet 1989;83:181–8. 39. Kimura M. Evolutionary rate at the molecular level. Nature 1968;217:624–6. 40. King JL, Jukes TH. Non-Darwinian evolution. Science 1969;164:788–98. 41. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD. Interrogating a high-density SNP map for signatures of natural selection. Genome Res 2002;12:1805–14. 42. Akey JM, Eberle MA, Rieder MJ, Carlson CS, Shriver MD, Nickerson DA, Kruglyak L. Population history and natural selection shape patterns of genetic variation in 132 genes. PLoS Biol 2004;2:e286. 43. Wooding S. Natural selection: Sign, sign, everywhere a sign. Curr Biol 2004;14:R700–1. 44. Collins FS. What we do and don’t know about ‘race’, ‘ethnicity’, genetics and health at the dawn of the genome era. Nat Genet 2004;36(11 suppl):S13–5. 45. Chakravarti A. To a future of genetic medicine. Nature 2001;409:822–3. 46. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001;17:502–10. 47. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001;69:124–37. 48. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: Common disease-common variant…or not? Hum Mol Genet 2002;11:2417–23. 49. Jorde LB, Watkins WS, Bamshad MJ. Population genomics: A bridge from evolutionary history to genetic medicine. Hum Mol Genet 2001;10:2199–207. 50. Jorde LB, Watkins WS, Bamshad MJ, Dixon ME, Ricker CE, Seielstad MT, Batzer MA. The distribution of human genetic diversity: A comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet 2000;66:979–88. 51. Jorde LB, Wooding SP. Genetic variation, classification and ‘race’. Nat Genet 2004;36(11 suppl):S28–33. 52. Bersaglieri T, Sabeti PC, Patterson N, Vanderploeg T, Schaffner SF, Drake JA, Rhodes M, Reich DE, Hirschhorn JN. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 2004; 74:1111–20. 53. Poulter M, Hollox E, Harvey CB, Mulcare C, Peuhkuri K, Kajander K, Sarner M, Korpela R, Swallow DM. The causal element for the lactase persistence/non-persistence polymorphism is located in a 1 Mb region of linkage disequilibrium in Europeans. Ann Hum Genet 2003;67(pt 4):298–311.
Human nutrition and genetic variation 54. Wooding S. PopHist: Inferring population history from the spectrum of allele frequencies. Bioinformatics 2003;19:539–40. 55. Toomajian C, Ajioka RS, Jorde LB, Kushner JP, Kreitman M. A method for detecting recent selection in the human genome from allele age estimates. Genetics 2003;165:287–97. 56. Toomajian C, Kreitman M. Sequence variation and haplotype structure at the human HFE locus. Genetics 2002;161:1609–23. 57. Beutler E. Iron absorption in carriers of the C282Y hemochromatosis mutation. Am J Clin Nutr 2004;80: 799–800. 58. Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 1986;6:502–10. 59. Osier MV, Pakstis AJ, Soodyall H, Comas D, Goldman D, Odunsi A, Okonofua F, Parnas J, Schulz LO, Bertranpetit J, Bonne-Tamir B, Lu RB, Kidd JR, Kidd KK. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet 2002;71:84–99. 60. Loew M, Boeing H, Sturmer T, Brenner H. Relation among alcohol dehydrogenase 2 polymorphism, alcohol consumption, and levels of gamma-glutamyltransferase. Alcohol 2003;29:131–5. 61. Oota H, Pakstis AJ, Bonne-Tamir B, Goldman D, Grigorenko E, Kajuna SL, Karoma NJ, Kungulilo S, Lu RB, Odunsi K, Okonofua F, Zhukova OV, Kidd JR, Kidd KK. The evolution and population genetics of the ALDH2 locus: Random genetic drift, selection, and low levels of recombination. Ann Hum Genet 2004;68(pt 2): 93–109. 62. Neel JV. Diabetes mellitus: A “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 1962;14:353–62. 63. Diamond J. The double puzzle of diabetes. Nature 2003;423:599–602. 64. Rockman MV, Wray GA. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002;19:1991–2004. 65. Verrelli BC, McDonald JH, Argyropoulos G, Destro- Bisol G, Froment A, Drousiotou A, Lefranc G, Helal AN, Loiselet J, Tishkoff SA. Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am J Hum Genet 2002;71:1112–28. 66. Watkins WS, Rogers AR, Ostler CT, Wooding S, Bamshad MJ, Brassington AM, Carroll ML, Nguyen SV, Walker JA, Prasad BV, Reddy PG, Das PK, Batzer MA, Jorde LB. Genetic variation among world populations: Inferences from 100 Alu insertion polymorphisms. Genome Res 2003;13:1607–18. 67. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarelli G, Touma EH, Williams SM, Clark AG. Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance. Science 2001;293:455–62. 68. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C. A calpain-10 gene poly- S113 morphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000;106: R69–73. 69. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786–97. 70. Wray GA, Hahn MW, Abouheif E, Balhoff JP, Pizer M, Rockman MV, Romano LA. The evolution of transcriptional regulation in eukaryotes. Mol Biol Evol 2003;20:1377–419. 71. Wright AF, Carothers AD, Pirastu M. Population choice in mapping genes for complex diseases. Nat Genet 1999;23:397–404. 72. Wooding S, Kim UK, Bamshad MJ, Larsen J, Jorde LB, Drayna D. Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet 2004;74:637–46. 73. Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): Relevance to genetic disease and polymorphisms. Am J Clin Nutr 2002;75:616–58. 74. Young VR. 2001 W.O. Atwater Memorial Lecture and the 2001 ASNS President’s Lecture: Human nutrient requirements: The challenge of the post-genome era. J Nutr 2002;132:621–9. 75. Siegal ML, Bergman A. Waddington’s canalization revisited: Developmental stability and evolution. Proc Natl Acad Sci USA 2002;99:10528–32. 76. Greenspan RJ. The flexible genome. Nat Rev Genet 2001;2:383–7. 77. Stover PJ. Nutritional genomics. Physiol Genomics 2004;16:161–5. 78. Stover PJ. Physiology of folate and vitamin B 12 in health and disease. Nutr Rev 2004;62(6 pt 2):S3–12; discussion S13. 79. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O’Leary VB, Parle-McDermott A, Scott JM, Swanson DA. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet 2002;71:1207–15. 80. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57:1098–102. 81. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 1999;6:359–65. 82. Esposito G, Vitagliano L, Santamaria R, Viola A, Zagari A, Salvatore F. Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance. FEBS Lett 2002;531:152–6. 83. Fullerton SM, Clark AG, Weiss KM, Nickerson DA,
Page 1 and 2:
Contents International harmonizatio
Page 3 and 4:
Executive summary Harmonization of
Page 5 and 6:
Executive summary [11]. These are l
Page 7 and 8:
Executive summary and converted to
Page 9 and 10:
Executive summary very rapidly and
Page 11 and 12:
Executive summary References Concep
Page 13 and 14:
Introduction Janet C. King and Cutb
Page 15 and 16:
Introduction References 1. King JC,
Page 17 and 18:
Terminology and framework for nutri
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Nutrient risk assessment: Setting u
Page 29 and 30:
Setting upper levels for nutrient r
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Establishing nutrient intake values
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Methods for using nutrient intake v
Page 53 and 54:
Using nutrient intake values to ass
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62: Determining life-stage groups and e
Page 63 and 64: Life-stage groups and nutrient inta
Page 77 and 78: The role of diet- and host-related
Page 79 and 80: Diet- and host-related factors in n
Page 101 and 102: Human nutrition and genetic variati
Page 111: Human nutrition and genetic variati
Page 117 and 118: Application of nutrient intake valu
Page 123 and 124: Trade, development, and regulatory
Page 141 and 142: Beyond recommendations: Implementin
Page 143 and 144: Dietary guidelines and nutrient int
Page 153: International Dietary Harmonization
show all

Implementing food-based dietary guidelines for - United Nations ...

Create successful ePaper yourself

Delete template?

Save as template?